Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02507843Phase 4Unknown
Phase 4, randomised, double-blind trial in Non-cystic fibrosis bronchiectasis (NCFB) comparing Vitamin D group with Placebo group (2 arms). Primary endpoint: Time to first acute exacerbation at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02507843.